eXp Realty Adds Top Agents Across Country
Mar 14, 2018 13:00 pm UTC| Business
BELLINGHAM, Wash., March 14, 2018 -- eXp Realty, the largest residential real estate brokerage by geography in North America and a subsidiary of eXp World Holdings, Inc. (OTCQB:EXPI), today introduced new top agents to...
DC Event Features Bipartisan Congressional Panel on Reentry Reform
Mar 14, 2018 13:00 pm UTC| Business
Lansdowne, VA, March 14, 2018 -- Prison Fellowship, the nation’s largest Christian nonprofit serving prisoners, former prisoners, and their families, is hosting a panel discussion on reentry reform issues this...
Plumas Bancorp Ranked 5th Best Performing Community Bank in the Nation
Mar 14, 2018 13:00 pm UTC| Business
QUINCY, Calif., March 14, 2018 -- Plumas Bancorp (NASDAQ:PLBC), the holding company (the “Company”) for Plumas Bank , was recently awarded the prestigious Community Bankers Cup by Raymond James Associates for operating...
IGC Partners to Advance Cannabinoid Based Parkinson's Disease Therapy Research -- CFN Media
Mar 14, 2018 13:00 pm UTC| Business
Seattle, WA , March 14, 2018 -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering India Globalization Capital...
Datorama Introduces LiteConnect for AI-powered Marketing Data Visualization and Insights
Mar 14, 2018 13:00 pm UTC| Business
NEW YORK, March 14, 2018 -- Datorama, a leading global technology company, has announced the launch of a complementary solution within its marketing intelligence platform. LiteConnect is an all-new, patent-pending...
Amedisys to Present at the 28th Annual Oppenheimer Healthcare Conference
Mar 14, 2018 13:00 pm UTC| Business
BATON ROUGE, La., March 14, 2018 -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will...
Zynerba Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference
Mar 14, 2018 13:00 pm UTC| Business
DEVON, Pa., March 14, 2018 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative...